Incidence and mortality of alcohol-related hepatitis in Denmark – an update, 2016–2023

Background & Aims: Alcohol-related hepatitis (AH) is a severe liver disease associated with high mortality. This study provides data on the incidence and mortality of AH in Denmark from 2016 to 2023. Methods: We identified all patients with a first-time hospital discharge diagnosis of AH and...

Full description

Saved in:
Bibliographic Details
Main Authors: Khaibar Ghulam Hazrat, Sidsel Hyldgaard Støy, Thomas Damgaard Sandahl, Peter Jepsen
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:JHEP Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589555925000679
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849434507407523840
author Khaibar Ghulam Hazrat
Sidsel Hyldgaard Støy
Thomas Damgaard Sandahl
Peter Jepsen
author_facet Khaibar Ghulam Hazrat
Sidsel Hyldgaard Støy
Thomas Damgaard Sandahl
Peter Jepsen
author_sort Khaibar Ghulam Hazrat
collection DOAJ
description Background & Aims: Alcohol-related hepatitis (AH) is a severe liver disease associated with high mortality. This study provides data on the incidence and mortality of AH in Denmark from 2016 to 2023. Methods: We identified all patients with a first-time hospital discharge diagnosis of AH and a serum bilirubin level >3 mg/dl in 2016–2023. We computed the standardized incidence rate of AH in the Danish population and mortality from admission with AH. We compared the results to our previously published findings for the 1999-2008 period. Results: We included 1,016 patients with a median age of 54.7 years (66% men). The standardized incidence rate was 21.7 per million per year, which remained stable during the study period for both men and women. Mortality was high: 18% at 28 days, 26% at 84 days, and 40% at 365 days. Although 28-day and 84-day mortality risks were lower in 2023 compared to earlier years, no overall trend of improvement was observed. The median MELD score at admission, available for 846 patients, was consistently high at 26, and 75% had severe AH (MELD >21). Compared to an incidence rate of approximately 45 per million per year in 2009, the incidence of AH has since decreased dramatically, mirroring Danish alcohol sales. Conclusions: The incidence of AH in Denmark markedly declined from 2009 but stabilized between 2016 and 2023. Mortality remains high, emphasizing the need for better treatment strategies. Impact and implications: This study investigated the incidence and mortality of alcohol-related hepatitis (AH) in Denmark from 2016 to 2023, providing updated data in the context of declining alcohol consumption. While AH incidence has decreased since 2009, mirroring reduced alcohol intake, it has stabilized in recent years, and mortality remains high. These findings highlight the ongoing burden of AH for healthcare providers, researchers, and policymakers. Our results can support early interventional strategies, guide clinical management, and reinforce public health efforts to reduce alcohol consumption. Limitations, such as the lack of detailed treatment data, should be considered to avoid overgeneralization.
format Article
id doaj-art-d25ea43181c945538d1b27a0bbd77c38
institution Kabale University
issn 2589-5559
language English
publishDate 2025-06-01
publisher Elsevier
record_format Article
series JHEP Reports
spelling doaj-art-d25ea43181c945538d1b27a0bbd77c382025-08-20T03:26:38ZengElsevierJHEP Reports2589-55592025-06-017610139010.1016/j.jhepr.2025.101390Incidence and mortality of alcohol-related hepatitis in Denmark – an update, 2016–2023Khaibar Ghulam Hazrat0Sidsel Hyldgaard Støy1Thomas Damgaard Sandahl2Peter Jepsen3Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, DenmarkDepartment of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, DenmarkDepartment of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark; Corresponding author. Address: Department of Hepatology and Gastroenterology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, C116, DK-8200 Aarhus N, Denmark.Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Epidemiology, Aarhus University Hospital, DenmarkBackground & Aims: Alcohol-related hepatitis (AH) is a severe liver disease associated with high mortality. This study provides data on the incidence and mortality of AH in Denmark from 2016 to 2023. Methods: We identified all patients with a first-time hospital discharge diagnosis of AH and a serum bilirubin level >3 mg/dl in 2016–2023. We computed the standardized incidence rate of AH in the Danish population and mortality from admission with AH. We compared the results to our previously published findings for the 1999-2008 period. Results: We included 1,016 patients with a median age of 54.7 years (66% men). The standardized incidence rate was 21.7 per million per year, which remained stable during the study period for both men and women. Mortality was high: 18% at 28 days, 26% at 84 days, and 40% at 365 days. Although 28-day and 84-day mortality risks were lower in 2023 compared to earlier years, no overall trend of improvement was observed. The median MELD score at admission, available for 846 patients, was consistently high at 26, and 75% had severe AH (MELD >21). Compared to an incidence rate of approximately 45 per million per year in 2009, the incidence of AH has since decreased dramatically, mirroring Danish alcohol sales. Conclusions: The incidence of AH in Denmark markedly declined from 2009 but stabilized between 2016 and 2023. Mortality remains high, emphasizing the need for better treatment strategies. Impact and implications: This study investigated the incidence and mortality of alcohol-related hepatitis (AH) in Denmark from 2016 to 2023, providing updated data in the context of declining alcohol consumption. While AH incidence has decreased since 2009, mirroring reduced alcohol intake, it has stabilized in recent years, and mortality remains high. These findings highlight the ongoing burden of AH for healthcare providers, researchers, and policymakers. Our results can support early interventional strategies, guide clinical management, and reinforce public health efforts to reduce alcohol consumption. Limitations, such as the lack of detailed treatment data, should be considered to avoid overgeneralization.http://www.sciencedirect.com/science/article/pii/S2589555925000679Alcohol-related liver diseaseepidemiologypublic health
spellingShingle Khaibar Ghulam Hazrat
Sidsel Hyldgaard Støy
Thomas Damgaard Sandahl
Peter Jepsen
Incidence and mortality of alcohol-related hepatitis in Denmark – an update, 2016–2023
JHEP Reports
Alcohol-related liver disease
epidemiology
public health
title Incidence and mortality of alcohol-related hepatitis in Denmark – an update, 2016–2023
title_full Incidence and mortality of alcohol-related hepatitis in Denmark – an update, 2016–2023
title_fullStr Incidence and mortality of alcohol-related hepatitis in Denmark – an update, 2016–2023
title_full_unstemmed Incidence and mortality of alcohol-related hepatitis in Denmark – an update, 2016–2023
title_short Incidence and mortality of alcohol-related hepatitis in Denmark – an update, 2016–2023
title_sort incidence and mortality of alcohol related hepatitis in denmark an update 2016 2023
topic Alcohol-related liver disease
epidemiology
public health
url http://www.sciencedirect.com/science/article/pii/S2589555925000679
work_keys_str_mv AT khaibarghulamhazrat incidenceandmortalityofalcoholrelatedhepatitisindenmarkanupdate20162023
AT sidselhyldgaardstøy incidenceandmortalityofalcoholrelatedhepatitisindenmarkanupdate20162023
AT thomasdamgaardsandahl incidenceandmortalityofalcoholrelatedhepatitisindenmarkanupdate20162023
AT peterjepsen incidenceandmortalityofalcoholrelatedhepatitisindenmarkanupdate20162023